logo-loader
THC Global Group Ltd

THC Global has news pending on grant of a Manufacture Licence by Office of Drug Control

The company has been granted a trading halt which will remain in place until the start of trading on June 14 or when an announcement is released to the market.

Cannabis leaves and medical bottle
THC Global is well-placed to be a major competitor within the cannabis sector

THC Global Group Ltd (ASX:THC) is in a trading halt with an announcement pending with respect to the grant of a Manufacture Licence by the Office of Drug Control (ODC).

The halt will remain in place until the start of normal trading on the ASX on Friday, June 14, 2019, or when an announcement is released to the market.

Shares last traded this morning before the halt at 44 cents, up more than 2% on Tuesday's close.

READ: THC Global Group focuses on building a global cannabis company

THC Global is focused on building a global, diversified and vertically integrated cannabis company reflecting newer and greater opportunities.

Addressing the company’s recent annual general meeting, chairman Steven Xu said that with key infrastructure secured to begin the manufacturing within Australia of high-grade pharmaceutical cannabis products, the company was entering the lucrative Canadian cannabis market.

READ: THC Global raises nearly $3 million to fund transition into full-scale medicinal cannabis production

He said: “We are also continuing to expand our hydroponics equipment business, Crystal Mountain, based in Vancouver into the UK and European markets.

“Compared to our peers, we see THC Global as being in prime position to be a significant competitor within the global cannabis sector as we have secured large-scale assets, experienced talent and key commercial partnerships.

“This allows us to structure our future business growth towards near-term strong revenue generation.

“Within Australia we have commenced operations under our medicinal cannabis licences for R&D and cultivation at our Strain R&D and second manufacturing site in south-eastern Queensland.

“This site is also awaiting a manufacturing licence to allow for smaller-scale manufacturing to complement the existing R&D and cultivation programs at the site.”

READ: THC Global shares rise after securing medicinal cannabis export licence

Earlier this year, THC Global was granted a medicinal cannabis export licence by the Australian ODC.

This is a key milestone in developing a future export pathway of THC Global’s Australian cannabis and places the company in an increasingly stronger position to take advantage of its industry leading manufacturing capability and its global reach.

Quick facts: THC Global Group Ltd

Price: $0.48

Market: ASX
Market Cap: $65.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

THC Global granted manufacturing licence by Australian Office of Drug Control

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive Investors on the manufacturing licence granted to the cannabis company by the Australian Office of Drug Control.   "It's a significnat milestone ... we now are a farm-to-pharma process which...

on 06/12/2019

2 min read